e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
COPD diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Skin autofluorescence is not a good marker for disease status in COPD
P. Gopal, E. Rutten, N. Reynaert, N. Ten Hacken, E. Wouters (Maastricht, Horn, Groningen, Netherlands)
Source:
Annual Congress 2011 - COPD diagnosis
Session:
COPD diagnosis
Session type:
Thematic Poster Session
Number:
3573
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Gopal, E. Rutten, N. Reynaert, N. Ten Hacken, E. Wouters (Maastricht, Horn, Groningen, Netherlands). Skin autofluorescence is not a good marker for disease status in COPD. Eur Respir J 2011; 38: Suppl. 55, 3573
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Markers of early disease and prognosis in COPD
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Ultrasound diaphragm activity as a marker of clinical status and prognosis in acute exacerbations of COPD
Source: Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD
Year: 2021
Lung function reversibility as a predictor of disease progression in COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Red cell distribution width (RDW) as a biomarker of disease severity in ILD patients
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
The relationship between bronchial inflammation and markers of disease progression in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 179s
Year: 2003
Functional status in patients with chronic lung disease
Source: Eur Respir J 2007; 30: Suppl. 51, 652s
Year: 2007
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001
Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
How beneficial might be using the Lüscher colour test in the psychological assessment of COPD patients?
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015
Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008
Chronic obstructive lung disease and vitamin D status: Relationship with lung function, inflammatory status and exacerbations
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Functional status in high and low risk patient with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD
Year: 2013
Effectiveness of a panel of sputum markers in smokers with and without COPD to detect pulmonary progression towards functional impairment
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Systemic inflammation and nutritive status in patients with COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020
Predicting progression of RA-ILD using anti-CCP
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Discrepancy of non-invasive inflammatory markers and lung function tests to current level of clinical control in childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Biological and phenomenological markers of ageing in patients with COPD and their relationship to CT emphysema scores
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept